# Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2

> **NCT02356276** · PHASE3 · UNKNOWN · sponsor: **Affiliated Cancer Hospital & Institute of Guangzhou Medical University** · enrollment: 584 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **PROCEDURE:** D2 lymphadenectomy
- **PROCEDURE:** Hyperthermic Intraperitoneal Chemotherapy
- **DRUG:** Systemic chemotherapy (XELOX or SOX regimens)

## Key facts

- **NCT ID:** NCT02356276
- **Lead sponsor:** Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05-11
- **Primary completion:** 2022-01
- **Final completion:** 2022-01
- **Target enrollment:** 584 (ESTIMATED)
- **Last updated:** 2017-10-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02356276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02356276, "Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02356276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*